Beam Therapeutics's total assets for Q2 2026 were $1.39B, a decrease of -6.38% from the previous quarter. MX:BEAM total liabilities were $319.19M for the fiscal quarter, a 0.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.